Orchestra BioMed Holdings, Inc.
OBIOHealthcare|Biotechnology|US
$5.68
+0.06 (+1.07%)
Tangible Book / Share
$0.46
Cash / Share
$1.72
Clinical Trials (2)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06059638 BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT | Hypertension, Hypertension, Systolic | N/A | Recruiting | 316 | RCT, Double-blind | — |
| NCT07045194 Virtue® SAB in the Treatment of Coronary ISR Trial | Coronary Artery Disease | N/A | Recruiting | 740 | RCT, Single-blind | — |